SKLB-016

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSKLB-016
Drug Alias NameSKLB-016
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSichuan University
Active IndicationsN/A
Inactive IndicationsFatty Liver

Other Information

ATC CodeN/A
Related LinksN/A